Evidence map›Paper›PMID 34737960›Full record

ArticleFrontiers in oncology2021

Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors.

Jhajaira M Araujo, Gina Rosas, Carolina Belmar-López, Luis E Raez, Christian D Rolfo, Luis J Schwarz, Ulises Infante-Huaytalla, Kevin J Paez, Luis R García, Hober Alvarado and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Sex-Biased Immunity: The Hidden Variable in Immuno-oncology.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Review
  2. Sex influences on tumor innervation.Biology of sex differences · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Sex-dependent different clinicopathological characterization of Epstein-Barr virus-associated gastric carcinoma: a large-scale study.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  8. The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Jhajaira M AraujoCentro de Investigación Básica y Traslacional, AUNA Ideas, Lima, Peru.
Gina RosasDepartamento de Patología, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
Carolina Belmar-LópezEscuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru.
Luis E RaezMemorial Cancer Institute/Memorial Health Care System, Florida International University (FIU), Pembroke Pines, FL, United States.
Christian D RolfoCenter for Thoracic Oncology/Tisch Cancer Institute, Mount Sinai, New York, NY, United States.
Luis J SchwarzEscuela Profesional de Medicina Humana-Filial Ica, Universidad Privada San Juan Bautista, Ica, Peru.
Ulises Infante-HuaytallaFacultad de Ciencias Biológicas, Universidad Nacional San Luis Gonzaga de Ica, Ica, Peru.
Kevin J PaezFacultad de Ciencias Biológicas, Universidad Nacional San Luis Gonzaga de Ica, Ica, Peru.
Luis R GarcíaFacultad de Ciencias Biológicas, Universidad Nacional San Luis Gonzaga de Ica, Ica, Peru.
Hober AlvaradoFacultad de Ciencias Biológicas, Universidad Nacional San Luis Gonzaga de Ica, Ica, Peru.
Fany P RamosFacultad de Ciencias Biológicas, Universidad Nacional San Luis Gonzaga de Ica, Ica, Peru.
Sheyla S Delgado-EspinozaFacultad de Ciencias Biológicas, Universidad Nacional San Luis Gonzaga de Ica, Ica, Peru.
Jhon B Cardenas-FarfanFacultad de Ciencias Biológicas, Universidad Nacional San Luis Gonzaga de Ica, Ica, Peru.
Melanie CornejoCentro de Investigación Básica y Traslacional, AUNA Ideas, Lima, Peru.
Daniel ZanabriaDepartamento de Patología, AUNA, Lima, Peru.
Christian Colonio-CossioDivisión de Riesgos, Oncosalud-AUNA, Lima, Peru.
Mario Rojas-JeffersonDivisión de Riesgos, Oncosalud-AUNA, Lima, Peru.
Joseph A PintoCentro de Investigación Básica y Traslacional, AUNA Ideas, Lima, Peru.
Saint Aloysius Gonzaga National University · PEUniversidad Privada San Juan Bautista · PEEsSALUD · PEGroup for the Analysis of Development · PEFlorida International University · USInstituto Nacional de Enfermedades Neoplásicas · PETisch Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSex is frequently underestimated as a prognostic biomarker in cancer. In this study, we evaluated a large cohort of patients and public datasets to determine the influence of sex on clinical outcomes, mutational status, and activation of immune pathways in different types of cancer.

methodsA cohort of 13,619 Oncosalud-affiliated patients bearing sex-unrelated cancers was followed over a 20-year period. Hazard ratios (HRs) for death were estimated for female

resultsOverall, women had a decreased risk of death (HR = 0.73, CI95: 8%-42%), with improved overall survival (OS) in HNC, leukemia, lung cancer, lymphoma, MEL, multiple myeloma (MM), and non-melanoma skin cancer. Regarding the analysis of actionable mutations, only differences in

conclusionsThe study shows an improved survival rate, increased activation of immune system pathways, and an enrichment of

Indexed as

actionable mutationsGSEAimmune gene setssexsurvival

Identifiers

PMID34737960
PMCPMC8562721
OpenAlexW3206962221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.